Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Selventa enters new collaboration

Feb. 29, 2012

Biodesix enters new collaboration

Feb. 28, 2012

Merck & Co. licenses Protein Sciences technology for vaccine research

Feb. 28, 2012

MorphoSys announces signing of protein engineering agreement

Feb. 28, 2012

Galen acquires chemotherapy agent from Gilead

Feb. 27, 2012

Angiochem and GSK launch new collaboration

Feb. 27, 2012

Auxilium grants Actelion exclusive rights to Xiaflex in certain territories

Feb. 23, 2012

Daiichi Sankyo and Terumo enter new vaccine collaboration

Feb. 23, 2012

Enanta out-licenses EDP-239 development

Feb. 23, 2012

Ligand Pharmaceuticals enters new licensing agreement

Feb. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...